Investors / Canada / iGan Partners
iGan Partners
Venture capital · Toronto, Canada · North America
iGan Partners is a healthcare-focused venture capital firm based in Toronto that invests in early-stage companies and provides follow-on funding through to exit. It supports founders commercializing healthcare technologies with capital, active support, and access to industry partners and co-investors.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordshealthcaremedtechdigital healthaimedical devices
Your fit with iGan Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsiGan Partners lists 17 checked portfolio companies on its own site and is named in 3 funding rounds, 3 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (79%), AI & Machine Learning (16%) and Cybersecurity (5%). 67% of its companies are based in Canada. It invests most often alongside MaRS IAF, Creative Destruction Lab and Lumira Ventures.
Counts come from funding rounds that name iGan Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not iGan Partners' whole history. Rounds on record name 3 companies; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 2 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 44th | 17 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 89th | 18% of companies confirmed by a round |
| Sector focus | 93th | 79% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| MaRS IAF | 4 |
| Creative Destruction Lab | 2 |
| Lumira Ventures | 2 |
| Arboretum Ventures | 1 |
| Archangel Network of Funds | 1 |
| BCF Ventures | 1 |
| Beedie Capital | 1 |
| Blumberg Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers17100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 79% | 15% |
| AI & Machine Learning | 16% | 18% |
| Cybersecurity | 5% | 4% |
Co-investor network
who it backs companies with, and who they back togetherCompare iGan Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with iGan Partners| Date | Company | Stage |
|---|---|---|
| 26 May 2026 | Series A Led | |
| 10 Feb 2026 | Round Led | |
| 7 Aug 2025 | Round Led |
Round details for iGan Partners
Amounts, full round histories and every co-investor in iGan Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adenocyte develops a solution using low intensity ultrasound to improve sample collection for cancer screening. | Healthcare & Biotech | May 2026Series A | Page + round | |
| Adracare provides virtual care and practice management software for healthcare practitioners | Healthcare & Biotech | Portfolio page | ||
| Cosm Medical develops personalized pessaries to treat pelvic floor disorders | Healthcare & Biotech | Portfolio page | ||
| CyborgDB provides a vector database for production AI with encrypted and secure file sharing solutions | AI & Machine LearningCybersecurity | Portfolio page | ||
| DOCSI provides a surgical optimization solution focused on operating room supply chain management and optimization | Healthcare & Biotech | Aug 2025Round | Page + round | |
| eSight develops and sells electronic eyewear for people with low vision and legal blindness | Healthcare & Biotech | Portfolio page | ||
| Exact Imaging develops and provides micro-ultrasound technology for urologic imaging and biopsy | Healthcare & Biotech | Feb 2026Round | Page + round | |
| Flosonics develops and markets a wireless, wearable ultrasound device for real-time hemodynamic assessments to clinicians | Healthcare & Biotech | Portfolio page | ||
| Medchart digitizes and simplifies the request and release of health information for healthcare providers, lawyers, insurance providers, and patients. | Healthcare & Biotech | Portfolio page | ||
| MolecuLight develops and provides advanced wound care devices for diagnostic imaging | Healthcare & Biotech | Portfolio page | ||
| Okadoc allows users to book an appointment with their doctor online | Healthcare & Biotech | Portfolio page | ||
| RetiSpec develops a point of care and AI-driven early detection of Alzheimer's, through a simple eye exam. | Healthcare & Biotech | Portfolio page | ||
| Rna Diagnostics develops a predictive biomarker platform to measure tumor response to cancer drugs and guide oncology treatment decisions. | Healthcare & Biotech | Portfolio page | ||
| Sciteline provides digital solutions for clinical research, including recruitment, eSource, and decentralized clinical trial tools. | Healthcare & Biotech | Portfolio page | ||
| Segmed offers millions of regulatory-grade medical images to streamline innovation and meet the evidence needs of researchers at life sciences and technology companies. | Healthcare & Biotech | Portfolio page | ||
| SomaDetect provides dairy farmers with real-time data and insights to improve herd health, reduce costs, and maximize production. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Think Research combines clinical expertise, software, and hands-on operational support to improve how care is delivered in health systems. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- iganpartners.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 7 Aug 2025
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get iGan Partners' profile as data
Pull iGan Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/iganpartners.com
# also
GET /v1/firms/iganpartners.com/portfolio
GET /v1/firms/iganpartners.com/coinvestors
GET /v1/firms/iganpartners.com/news